A GEM: OBMP is One of the Best Cheap OTC Penny Pharmachutical Stock to watch in 2018 I think. It is an emerging potential top-tier prostate cancer play in the making. It’s ProscaVax pipeline asset is moving toward a huge Phase II trial, which will go a long ways toward putting this company in the $7.1 billion prostate cancer treatment space.